Table 1.
Description of newly enrolled and eligible T2DM patients in the cohort by calendar year.
| N (%) | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | P value* |
|---|---|---|---|---|---|---|---|
| Overall | 48 289 (20.1) | 47 506 (19.7) | 49 125 (20.4) | 39 133 (16.3) | 32 836 (13.6) | 23 803 (9.9) | |
| Age group (years) | <0.001 | ||||||
| 35–44 | 1801 (3.7) | 1650 (3.5) | 1606 (3.3) | 1197 (3.1) | 915 (2.8) | 610 (2.6) | |
| 45–54 | 10 699 (22.2) | 9427 (19.8) | 8846 (18.0) | 5862 (15.0) | 4543 (13.8) | 2873 (12.1) | |
| 55–64 | 18 197 (37.7) | 17 920 (37.7) | 18 263 (37.2) | 14 857 (38.0) | 12 245 (37.3) | 8452 (35.5) | |
| 65–74 | 10 953 (22.7) | 11 073 (23.3) | 12 347 (25.1) | 10 152 (25.9) | 8881 (27.1) | 6903 (29.0) | |
| 75– | 6639 (13.8) | 7436 (15.7) | 8063 (16.4) | 7065 (18.1) | 6252 (19.0) | 4965 (20.9) | |
| Sex | 0.001 | ||||||
| Men | 21 843 (45.2) | 21 557 (45.4) | 22 801 (46.4) | 17 929 (45.8) | 15 110 (46.0) | 11 022 (46.3) | |
| Women | 26 446 (54.8) | 25 949 (54.6) | 26 324 (53.6) | 21 204 (54.2) | 17 726 (54.0) | 12 781 (53.7) |
*P values were calculated using a Chi-square test.